title: A comparison of two intravenous infusion devices in lung carcinoma patients receiving combined radiotherapy and chemotherapy.
abstract: OBJECTIVE
  To investigate the clinical effects of intravenous (IV) devices in the patients with lung cancer undergoing radiotherapy and chemotherapy.
  
  
  METHODS
  A total of 128 patients were divided into two groups : t0 hose who received chemotherapy through a peripherally inserted central catheter (PICC group; n = 64), and those who received therapy through an IV remaining needle (n = 64).
  
  
  METHODS
  Patient characteristics and complication rates were compared using Fisher's exact tests or the χ2 test. During the treatment times, the time and the average nursing costs for both infusion methods and their complications were compared using the student's t -test. Data is presented as mean ± SEM 0 P value <0.05 was considered significant. Statistical analyses were carried out using SPSS V.12.0 for Windows (SPSS, Inc.).
  
  
  CONCLUSIONS
  The non-retention type venous detaining needle appears to be the preferred patient choice for those undergoing combined radiotherapy and chemotherapy.
authors: Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, China.
authors: Xing-Hua
authors: XH
authors: Bai
authors: Shuang
authors: S
authors: Zang
authors: Ling
authors: L
authors: Yu
mesh_terms: D061605:Administration, Intravenous / Q000009:adverse effects / Q000379:methods*; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy; D002406:Catheterization, Peripheral / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods; D003131:Combined Modality Therapy / Q000295:instrumentation / Q000379:methods; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D010358:Patient Participation; D062666:Vascular Access Devices / Q000009:adverse effects*